In addition, TNF blockers have been associated with the development of autoimmune diseases, such as paradoxical psoriasis, demyelinating central nervous system disease, vasculitis, and lupus-like syndrome [9,15]. This evidence concerns the gene TNF and drug-induced lupus erythematosus.